The Application of SUDOSCAN for Screening Diabetic Peripheral Neuropathy in Chinese Population Screening DPN by SUDOSCAN
received 07 June 2017
first decision 07 June 2017
accepted 13 July 2017
11 September 2017 (eFirst)
Purpose Diabetic peripheral neuropathies are the common chronic complications of diabetes, but the diagnosis is insensitive by physical examination in busy outpatients. Here we evaluated the performance of SUDOSCAN in screening diabetic peripheral neuropathies in Chinese type 2 diabetic patients.
Methods The study enrolled 180 patients for annually screening. All patients underwent neurological symptoms assessment, clinical examination, nerve conduction studies and cardiovascular autonomic reflex tests. SUDOSCAN was tested and evaluated with electrochemical skin conductance in hands and feet, asymmetry ratio in hands and feet and predicted cardiac neuropathy.
Results Patients enrolled had an average age of 56.1 years, 9.8 years of diabetic duration. Patients with diabetic sensorimotor polyneuropathy showed significantly lower electrochemical skin conductance in feet and higher asymmetry ratio in feet compared with those without. Sensitivity and specificity of asymmetry ratio in feet for diagnosing diabetic sensorimotor polyneuropathy were 88.2% and 46.9% and area under ROC curve was 0.713. Patients with cardiovascular autonomic neuropathy showed significantly lower electrochemical skin conductance in hands and feet, and higher asymmetry ratio in feet and predicted cardiac neuropathy compared with those without. Sensitivity and specificity of electrochemical skin conductance in feet in diagnosing cardiovascular autonomic neuropathy were 85.6% and 76.1% with an area under ROC curve of 0.859.
Conclusions SUDOSCAN is a sensitive test to detect diabetic peripheral neuropathy in China and could be an effective screening tool in in busy outpatients and primary health care.
Key wordscardiovascular autonomic neuropathy - diabetic sensorimotor polyneuropathy - SUDOSCAN - type 2 diabetes - Chinese population
* These authors contributed equally to this work.
- 1 Xu Y, Wang L, He J. et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013; 310: 948-959
- 2 Tesfaye S, Boulton AJ, Dyck PJ. et al. Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285-2293
- 3 Spallone V, Ziegler D, Freeman R. et al. Cardiovascular autonomic neuropathy in diabetes: Clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011; 27: 639-653
- 4 Lauria G, Hsieh ST, Johansson O. et al. European federation of neurological societies/peripheral nerve society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010; 17: 903-912 e944-909
- 5 England JD, Gronseth GS, Franklin G. et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72: 177-184
- 6 Casellini CM, Parson HK, Richardson MS. et al. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. Diabetes Technol Ther 2013; 15: 948-953
- 7 Vinik AI, Nevoret ML, Casellini C. The new age of sudomotor function testing: a sensitive and specific biomarker for diagnosis, estimation of severity, monitoring progression, and regression in response to intervention. Front Endocrinol (Lausanne) 2015; 6: 94
- 8 Selvarajah D, Cash T, Davies J. et al. SUDOSCAN: A simple, rapid, and objective method with potential for screening for diabetic peripheral neuropathy. PLoS One 2015; 10: e0138224
- 9 Michaelis D, Rjasanowski I, Hildmann W. et al. Validity of WHO criteria for classification of newly diagnosed diabetics. Exp Clin Endocrinol 1985; 85: 61-69
- 10 Young MJ, Boulton AJ, MacLeod AF. et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154
- 11 Dyck PJ, Sherman WR, Hallcher LM. et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980; 8: 590-596
- 12 Novak P. Quantitative Autonomic Testing. Jove-Journal of Visualized Experiments 2011
- 13 Martin CL, Albers JW, Pop-Busui R. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 2014; 37: 31-38
- 14 Korei AE, Istenes I, Papanas N. et al. Small-fiber neuropathy: A diabetic microvascular complication of special clinical, diagnostic, and prognostic importance. Angiology 2016; 67: 49-57
- 15 Smith AG, Lessard M, Reyna S. et al. The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy. J Diabetes Complications 2014; 28: 511-516
- 16 Novak P. Electrochemical skin conductance correlates with skin nerve fiber density. Front Aging Neurosci 2016; 8: 199
- 17 Mao F, Liu S, Qiao X et al. Sudoscan is an effective screening method for asymptomatic diabetic neuropathy in Chinese type 2 diabetes mellitus patients. J Diabetes Investig. 2016;